Stocks and Investing
Stocks and Investing
Thu, October 27, 2022
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
John Ransom Maintained (THC) at Strong Buy with Decreased Target to $80 on, Oct 27th, 2022
John Ransom of Raymond James, Maintained "Tenet Healthcare Corporation" (THC) at Strong Buy with Decreased Target from $135 to $80 on, Oct 27th, 2022.
John has made no other calls on THC in the last 4 months.
There are 11 other peers that have a rating on THC. Out of the 11 peers that are also analyzing THC, 1 agrees with John's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Scott Fidel of "Stephens & Co." Maintained at Hold with Decreased Target to $45 on, Monday, October 24th, 2022
These are the ratings of the 10 analyists that currently disagree with John
- Jason Cassorla of "Citigroup" Maintained at Strong Buy with Decreased Target to $76 on, Tuesday, October 25th, 2022
- Whit Mayo of "SVB Leerink" Maintained at Buy with Decreased Target to $55 on, Tuesday, October 25th, 2022
- Pito Chickering of "Deutsche Bank" Maintained at Strong Buy with Decreased Target to $48 on, Monday, October 24th, 2022
- Sarah James of "Barclays" Maintained at Buy with Decreased Target to $67 on, Monday, October 24th, 2022
- Stephen Baxter of "Wells Fargo" Maintained at Buy with Decreased Target to $48 on, Monday, October 24th, 2022
- Ann Hynes of "Mizuho" Maintained at Strong Buy with Increased Target to $80 on, Tuesday, August 2nd, 2022
- Andrew Mok of "UBS" Maintained at Strong Buy with Decreased Target to $91 on, Thursday, July 28th, 2022
- David Macdonald of "Truist Securities" Maintained at Strong Buy with Increased Target to $80 on, Monday, July 25th, 2022
- Frank Morgan of "RBC Capital" Maintained at Buy with Decreased Target to $99 on, Monday, July 25th, 2022
- Jamie Perse of "Goldman Sachs" Maintained at Strong Buy with Decreased Target to $93 on, Tuesday, July 12th, 2022
Contributing Sources